Sex hormones and the connective tissue diseases II: the pros and cons of estrogens and estrogen receptor modulators in patients with connective tissue diseases.
Draper
M W
MW
Lilly Research Laboratories, Department of Medicine, Indiana University School of Medicine, USA. mwd@lilly.com
D003240:Connective Tissue Diseases / Q000188:drug therapy* / Q000378:metabolism*; D004967:Estrogens / Q000627:therapeutic use*; D012739:Gonadal Steroid Hormones / Q000378:metabolism*; D006801:Humans; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*
D004967:Estrogens; D012739:Gonadal Steroid Hormones; D020845:Selective Estrogen Receptor Modulators